Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


14th Annual Drug Discovery Summit 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are proud to present the 14th Annual Drug Discovery Leaders Summit, taking place on 10 & 11 June in Geneva, Switzerland. The summit is made up of two co-located events: Innovation Driven Discovery and Discovery Chemistry & Drug Design.

The drug discovery industry faces a decade of monumental change – stem cell research, generic threat, big data challenges, PHC strategies and the growing focus on biologics all threaten to change the face of the global market. This long-established summit will explore the critical opportunities in drug discovery today, while updating key decision makers on the latest technological breakthroughs.

The Innovation Driven Discovery Congress explores new approaches to screening, assay development and target identification, while experts describe the data integration technologies capable of supporting this innovation. Our esteemed speaker panel will also discuss their strategies for harnessing external innovation and building effective collaborative working methods.

The Discovery Chemistry & Drug Design Congress features presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with our 5th Annual Drug Development Congress; a high-level meeting for those working at the forefront of research, development and translational medicine.



Further information
Scientific News
New Mechanism to Control Human Viral Infections Discovered
Researchers discover long sought after mechanism in human cells that could help treat diseases caused by viruses.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
RNAi Activated in Response to Influenza
Discovery could lead to better ways of combating serious infections, including Ebola and Zika.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Transporting Microscopic Cargo Between Human Cells
Scientists have developed a virus-inspired delivery system for material transport between cells.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Turning Off Asthma Attacks
Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks.
New Strategy May Drop Cancer’s Guard
Scientists eye ways to deconstruct tumors’ protective wall with current diabetes drug.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Smart Patch Releases Blood Thinners When Needed
Researchers have developed a smart patch that activelly monitors a patient's blood and releases blood thinning drugs when necessary.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!